These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31629575)

  • 21. Prospective analysis of coronary calcium in patients on dialysis undergoing a near-total parathyroidectomy.
    Daniel WT; Weber C; Bailey JA; Raggi P; Sharma J
    Surgery; 2013 Dec; 154(6):1315-21; discussion 1321-2. PubMed ID: 24238050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
    Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
    Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
    Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
    Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
    Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
    BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum parathyroid hormone and hypertension in hemodialysis patients.
    Sedighi O; Makhlough A; Kashi Z; Zahedi M
    Iran J Kidney Dis; 2011 Jul; 5(4):267-70. PubMed ID: 21725185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: role of phosphorus, calcium, and gender.
    Indridason OS; Pieper CF; Quarles LD
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3860-6. PubMed ID: 9814459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.
    Quarles LD; Sherrard DJ; Adler S; Rosansky SJ; McCary LC; Liu W; Turner SA; Bushinsky DA
    J Am Soc Nephrol; 2003 Mar; 14(3):575-83. PubMed ID: 12595492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
    Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
    Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
    Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
    Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-Reported Outcome Measures for Fatigue in Patients on Hemodialysis: A Systematic Review.
    Ju A; Unruh ML; Davison SN; Dapueto J; Dew MA; Fluck R; Germain M; Jassal SV; Obrador G; O'Donoghue D; Tugwell P; Craig JC; Ralph AF; Howell M; Tong A
    Am J Kidney Dis; 2018 Mar; 71(3):327-343. PubMed ID: 29198388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients.
    Malindretos P; Sarafidis P; Lazaridis A; Nikolaidis P
    Clin Nephrol; 2012 Mar; 77(3):196-203. PubMed ID: 22377250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
    Cooper K; Quarles D; Kubo Y; Tomlin H; Goodman W
    Nephron Clin Pract; 2012; 121(3-4):c124-30. PubMed ID: 23208191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients.
    Richter A; Kuhlmann MK; Seibert E; Kotanko P; Levin NW; Handelman GJ
    Nephrol Dial Transplant; 2008 Jun; 23(6):2058-63. PubMed ID: 18353890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
    Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
    J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic follow-up of the intact parathormone levels in hemodialysis patients treated with Rocaltrol and calcium.
    Dimitrakov D; Koumtchev E; Dimitrova R; Stavrev P
    Folia Med (Plovdiv); 1998; 40(4):48-53. PubMed ID: 10371800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
    Yokoyama K; Kurita N; Fukuma S; Akizawa T; Fukagawa M; Onishi Y; Kurokawa K; Fukuhara S
    Nephrol Dial Transplant; 2017 Mar; 32(3):534-541. PubMed ID: 26945054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet.
    Belozeroff V; Lee A; Tseng S; Chiroli S; Campbell JD
    J Med Econ; 2013 Sep; 16(9):1154-62. PubMed ID: 23869940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.